| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
AstraZeneca Pharma India Limited (NSE: ASTRAZEN)
ASTRAZEN Technical Analysis
3
| As on 2nd May 2024 ASTRAZEN SHARE Price closed @ 5357.80 and we RECOMMEND Buy for LONG-TERM with Stoploss of 4744.42 & Buy for SHORT-TERM with Stoploss of 5320.45 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ASTRAZENSHARE Price
| Open | 5206.00 | Change | Price | % |
| High | 5374.50 | 1 Day | 22.50 | 0.42 |
| Low | 5100.00 | 1 Week | 25.55 | 0.48 |
| Close | 5357.80 | 1 Month | 206.70 | 4.01 |
| Volume | 57226 | 1 Year | 2176.10 | 68.39 |
| 52 Week High 4518.45 | 52 Week Low 2460.65 | ||||
NSE INDIA Most Active Stocks
| IDEA | 13.20 | 0.00% |
| YESBANK | 25.45 | -2.68% |
| GTLINFRA | 1.75 | 2.94% |
| NHPC | 98.00 | 1.87% |
| RTNPOWER | 9.15 | -0.54% |
| SOUTHBANK | 29.20 | -5.04% |
| RECLTD | 553.90 | 9.22% |
| FEDERALBNK | 168.00 | 3.32% |
| GMRINFRA | 88.15 | 3.52% |
| TATASTEEL | 167.35 | 1.42% |
NSE INDIA Top Gainers Stocks
NSE INDIA Top Losers Stocks
| ASTRAZEN Daily Charts |
ASTRAZEN Intraday Charts |
Whats New @ Bazaartrend |
ASTRAZEN Free Analysis |
|
|
ASTRAZEN Important Levels Intraday
| RESISTANCE | 5886.76 |
| RESISTANCE | 5717.12 |
| RESISTANCE | 5612.26 |
| RESISTANCE | 5507.40 |
| SUPPORT | 5208.20 |
| SUPPORT | 5103.34 |
| SUPPORT | 4998.48 |
| SUPPORT | 4828.84 |
ASTRAZEN Target May 2024
| 4th UP Target | 6661.17 |
| 3rd UP Target | 6192.76 |
| 2nd UP Target | 5903.22 |
| 1st UP Target | 5613.68 |
| 1st DOWN Target | 4787.52 |
| 2nd DOWN Target | 4497.98 |
| 3rd DOWN Target | 4208.44 |
| 4th DOWN Target | 3740.03 |
ASTRAZEN Weekly Target
| 4th UP Target | 6176.37 |
| 3rd UP Target | 5935.66 |
| 2nd UP Target | 5786.87 |
| 1st UP Target | 5638.08 |
| 1st DOWN Target | 5213.52 |
| 2nd DOWN Target | 5064.73 |
| 3rd DOWN Target | 4915.94 |
| 4th DOWN Target | 4675.23 |
ASTRAZEN Target2024
| 4th UP Target | 11012.8 |
| 3rd UP Target | 9253.32 |
| 2nd UP Target | 8165.77 |
| 1st UP Target | 7078.22 |
| 1st DOWN Target | 3974.99 |
| 2nd DOWN Target | 2887.43 |
| 3rd DOWN Target | 1799.88 |
| 4th DOWN Target | 40.43 |
AstraZeneca Pharma India Limited ( NSE INDIA Symbol : ASTRAZEN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ASTRAZEN Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is Below 30 | Over Sold | |
| MFI (14) | MFI is 34.39 | Sideways | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is Below -80 | Over Sold | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 2403.43 | |
| 10 Day Avg Volume | Traded -38.65 % Less then 10 Day Average Volume | ||
ASTRAZEN Other Details
| Segment | EQ | |
| Market Capital | 76677439488.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > | |
ASTRAZEN Address
 |
||
ASTRAZEN Latest News
ASTRAZEN Business Profile
AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and distributes pharmaceutical products in India and internationally. It manufactures and sells medicines under the Brilinta, Betaloc, Crestor, Forxiga, Imdur, Kombiglyze XR, Onglyza, Seloken XL, Xigduo XR, QTERN, Symbicort, LYNPARZA, Tagrisso, Iressa, Calquence, Casodex, Faslodex, Zoladex, and Arimidex brands. The company offers products in the areas of cardiovascular, renal, metabolic, oncology, respiratory, inflammation, and autoimmunity diseases. It also provides clinical trial services. The company was incorporated in 1979 and is headquartered in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB. Address: Manyata Embassy Business Park, Bengaluru, India, 560045
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service